NEUROFIBROMATOSIS 1 (NF1)
Clinical trials for NEUROFIBROMATOSIS 1 (NF1) explained in plain language.
Never miss a new study
Get alerted when new NEUROFIBROMATOSIS 1 (NF1) trials appear
Sign up with your email to follow new studies for NEUROFIBROMATOSIS 1 (NF1), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for NF1 patients: drug shows promise against inoperable tumors
Disease control OngoingThis study tests the drug selumetinib in adults with neurofibromatosis type 1 (NF1) who have nerve tumors called plexiform neurofibromas that cannot be surgically removed. The goal is to see if the drug can shrink these tumors or slow their growth. Participants take selumetinib c…
Matched conditions: NEUROFIBROMATOSIS 1 (NF1)
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 11:35 UTC
-
Laser zaps NF1 skin bumps in new trial
Symptom relief TerminatedThis study tests whether monthly alexandrite laser treatments can safely shrink skin tumors in people with Neurofibromatosis Type 1 (NF1). Ten adults will receive up to six laser sessions, with some areas cooled to improve comfort. Researchers will measure tumor size, appearance,…
Matched conditions: NEUROFIBROMATOSIS 1 (NF1)
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated May 12, 2026 13:40 UTC